Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
10m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
38m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Gain Therapeutics Inc logo

Gain Therapeutics Inc

About

Gain Therapeutics Inc (NASDAQ:GANX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 24 2026
Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026
Mar 26 2026
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
Mar 19 2026
Gain Therapeutics to Present at the 38th Annual ROTH Conference
Mar 18 2026
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
Mar 12 2026
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update

Financials

Revenue
$0
Market Cap
$79.03 M
EPS
-0.61

Community Chat

Ask AI

6ix6ixAIEvents